Thomas A. Luger

43.3k total citations · 6 hit papers
513 papers, 27.5k citations indexed

About

Thomas A. Luger is a scholar working on Dermatology, Immunology and Immunology and Allergy. According to data from OpenAlex, Thomas A. Luger has authored 513 papers receiving a total of 27.5k indexed citations (citations by other indexed papers that have themselves been cited), including 260 papers in Dermatology, 152 papers in Immunology and 101 papers in Immunology and Allergy. Recurrent topics in Thomas A. Luger's work include Dermatology and Skin Diseases (188 papers), melanin and skin pigmentation (67 papers) and Allergic Rhinitis and Sensitization (66 papers). Thomas A. Luger is often cited by papers focused on Dermatology and Skin Diseases (188 papers), melanin and skin pigmentation (67 papers) and Allergic Rhinitis and Sensitization (66 papers). Thomas A. Luger collaborates with scholars based in Germany, United States and Austria. Thomas A. Luger's co-authors include Sonja Ständer, Dieter Metze, Markus Böhm, Thomas Schwarz, Thomas Schwarz, Martin Steinhoff, John C. Ansel, Thomas Scholzen, Thomas Brzoska and Stephan Grabbe and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Thomas A. Luger

506 papers receiving 26.6k citations

Hit Papers

Nanomedicine—Challenge an... 1990 2026 2002 2014 2009 2016 1990 2000 2018 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nanomedicine—Challenge and Perspectives
    2009 1.0k citations Thomas A. Luger et al. profile →
  2. Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
    2016 650 citations Thomas A. Luger et al. profile →
  3. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light.
    1990 616 citations Thomas Schwarz, Thomas A. Luger et al. profile →
  4. Corticotropin Releasing Hormone and Proopiomelanocortin Involvement in the Cutaneous Response to Stress
    2000 615 citations Thomas A. Luger et al. profile →
  5. The microbiome in patients with atopic dermatitis
    2018 345 citations Amy S. Paller, Heidi H. Kong et al. Journal of Allergy and Clinical Immunology profile →
  6. Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
    2016 281 citations Amy S. Paller, Thomas A. Luger et al. Journal of Investigative Dermatology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thomas A. Luger 11.5k 8.3k 4.4k 4.4k 3.4k 513 27.5k
Thomas Ruzicka 11.9k 1.0× 6.2k 0.7× 5.7k 1.3× 3.7k 0.9× 1.5k 0.4× 672 26.2k
Amy S. Paller 11.7k 1.0× 3.7k 0.5× 4.1k 0.9× 7.4k 1.7× 3.3k 0.9× 682 22.2k
Kenji Kabashima 10.9k 1.0× 7.6k 0.9× 3.1k 0.7× 6.8k 1.6× 828 0.2× 483 22.4k
Hideoki Ogawa 4.6k 0.4× 6.3k 0.8× 4.8k 1.1× 3.5k 0.8× 1.7k 0.5× 557 18.8k
John J. Voorhees 15.8k 1.4× 7.7k 0.9× 8.8k 2.0× 1.2k 0.3× 6.0k 1.7× 420 31.1k
Yoshiki Miyachi 5.0k 0.4× 4.6k 0.5× 3.8k 0.9× 1.7k 0.4× 1.7k 0.5× 506 15.9k
Peter M. Elias 19.7k 1.7× 3.1k 0.4× 10.6k 2.4× 5.0k 1.1× 6.2k 1.8× 488 37.6k
Wolfram Sterry 13.4k 1.2× 8.5k 1.0× 3.6k 0.8× 1.2k 0.3× 925 0.3× 671 27.1k
P.C.M. van de Kerkhof 8.0k 0.7× 8.9k 1.1× 1.6k 0.4× 979 0.2× 1.1k 0.3× 498 15.9k
Peter Valent 3.4k 0.3× 16.7k 2.0× 9.7k 2.2× 12.0k 2.8× 1.8k 0.5× 900 40.5k

Countries citing papers authored by Thomas A. Luger

Since Specialization
Citations

This map shows the geographic impact of Thomas A. Luger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Luger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Luger more than expected).

Fields of papers citing papers by Thomas A. Luger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Luger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Luger. The network helps show where Thomas A. Luger may publish in the future.

Co-authorship network of co-authors of Thomas A. Luger

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Luger. A scholar is included among the top collaborators of Thomas A. Luger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Luger. Thomas A. Luger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Magnolo, Nina, Thomas Jaenicke, Athanasios Tsianakas, et al.. (2023). Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial. Journal of the European Academy of Dermatology and Venereology. 37(S5). 18–26. 11 indexed citations
2.
Luger, Thomas A., et al.. (2023). Pimecrolimus 1% cream for mild-to-moderate atopic dermatitis: a systematic review and meta-analysis with a focus on children and sensitive skin areas. European Journal of Dermatology. 33(5). 474–486. 4 indexed citations
3.
Luger, Thomas A., Matthias Augustin, Julien Lambert, et al.. (2020). Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus. Pediatric Allergy and Immunology. 32(3). 414–424. 9 indexed citations
4.
Paller, Amy S., Heidi H. Kong, Patrick C. Seed, et al.. (2018). The microbiome in patients with atopic dermatitis. Journal of Allergy and Clinical Immunology. 143(1). 26–35. 345 indexed citations breakdown →
5.
Stadler, Rudolf, Roland Kaufmann, & Thomas A. Luger. (2014). Haut auf der Grenze zwischen Innen und Außen. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 12(s4). 70–71.
6.
Luger, Thomas A., F. Cambazard, Frederik Grønhøj Larsen, et al.. (2008). A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis. Dermatology. 217(4). 321–328. 75 indexed citations
7.
Metze, Dieter, et al.. (2008). Treatment of extra-abdominal aggressive fibromatosis with pegylated interferon. Journal of the American Academy of Dermatology. 59(2). S7–S9. 10 indexed citations
8.
Böhm, Markus, Zhuo Li, Stefan W. Schneider, et al.. (2005). Detection of Functionally Active Melanocortin Receptors and Evidence for an Immunoregulatory Activity of α-Melanocyte-Stimulating Hormone in Human Dermal Papilla Cells. Endocrinology. 146(11). 4635–4646. 46 indexed citations
9.
Metze, Dieter, et al.. (2004). Antipruritische Therapie mit dem oralen Opiatrezeptor-antagonisten Naltrexon: Offene, nicht placebokontrollierte Anwendung bei 133 patienten. Der Hautarzt. 55(12). 1130–1136. 5 indexed citations
10.
Ellis, Charles N. & Thomas A. Luger. (2003). International consensus conference on atopic dermatitis II (ICCAD II) Clinical update & current treatment strategies. British Journal of Dermatology. 148(63). 1–10. 6 indexed citations
11.
Raap, Ulrike, Thomas Brzoska, G Päth, et al.. (2003). α-Melanocyte-Stimulating Hormone Inhibits Allergic Airway Inflammation. The Journal of Immunology. 171(1). 353–359. 71 indexed citations
12.
Machens, Hans‐Günther, Thomas Aberle, Walther Burchard, et al.. (2002). Hydroxyethyl starch does not cross the blood-brain or the placental barrier but the perineurium of peripheral nerves in infused animals. Cell and Tissue Research. 310(3). 279–287. 26 indexed citations
13.
Steinhoff, Martin, Thomas Brzoska, & Thomas A. Luger. (2001). Keratinocytes in epidermal immune responses. Current Opinion in Allergy and Clinical Immunology. 1(5). 469–476. 35 indexed citations
14.
Kerkhof, P.C.M. van de, C.J.M. van der Vleuten, M. Gerritsen, et al.. (1997). Long-term efficacy and safety of once daily treatment of chronic plaque psoriasis with tacalcitol ointment. European Journal of Dermatology. 7(6). 421–425. 17 indexed citations
15.
Bhardwaj, Ranjit, Agatha Schwarz, Eva Becher, et al.. (1996). Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. The Journal of Immunology. 156(7). 2517–2521. 163 indexed citations
16.
17.
Aragane, Yoshinori, Helge Riemann, Ranjit Bhardwaj, et al.. (1994). Detection of the production of interleukin (IL) 12 by human keratinocytes. Journal of Investigative Dermatology. 103(3). 400. 2 indexed citations
18.
Luger, Thomas A., Werner Linkesch, Robert Knobler, & E. M. Kokoschka. (1983). Serial Determination of Serum Ferritin Levels in Patients with Malignant Melanoma. Oncology. 40(4). 263–267. 19 indexed citations
19.
Horn, Fabian, W. Gebhart, & Thomas A. Luger. (1978). [Transient acantholytic dermatosis (Grover) (author's transl)].. PubMed. 105(6-7). 581–5. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Ruzicka Breakdown of academic impact, for papers by Amy S. Paller Breakdown of academic impact, for papers by Kenji Kabashima Breakdown of academic impact, for papers by Hideoki Ogawa Breakdown of academic impact, for papers by John J. Voorhees Breakdown of academic impact, for papers by Yoshiki Miyachi Breakdown of academic impact, for papers by Peter M. Elias Breakdown of academic impact, for papers by Wolfram Sterry Breakdown of academic impact, for papers by P.C.M. van de Kerkhof Breakdown of academic impact, for papers by Peter Valent
Rankless by CCL
2026